Cargando…
Novel Blood–Brain Barrier Shuttle Peptides Discovered through the Phage Display Method
Delivery of therapeutic agents into the brain is a major challenge in central nervous system drug development. The blood–brain barrier (BBB) prevents access of biotherapeutics to their targets in the central nervous system and, therefore, prohibits the effective treatment of many neurological disord...
Autores principales: | Majerova, Petra, Hanes, Jozef, Olesova, Dominika, Sinsky, Jakub, Pilipcinec, Emil, Kovac, Andrej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070575/ https://www.ncbi.nlm.nih.gov/pubmed/32079185 http://dx.doi.org/10.3390/molecules25040874 |
Ejemplares similares
-
Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies
por: Majerova, Petra, et al.
Publicado: (2019) -
Tau Protein and Its Role in Blood–Brain Barrier Dysfunction
por: Michalicova, Alena, et al.
Publicado: (2020) -
GM3 Ganglioside Linked to Neurofibrillary Pathology in a Transgenic Rat Model for Tauopathy
por: Olešová, Dominika, et al.
Publicado: (2021) -
Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
por: Sinsky, Jakub, et al.
Publicado: (2021) -
Evaluation of Phage Display Discovered Peptides as Ligands for Prostate-Specific Membrane Antigen (PSMA)
por: Shen, Duanwen, et al.
Publicado: (2013)